GABAB Receptor: Structure, Biological Functions, and Therapy for Diseases

ABSTRACT Gamma‐aminobutyric acid (GABA) B receptors (GABABRs) that acts slowly and maintains the inhibitory tone are versatile regulators in the complex nervous behaviors and their involvement in various neuropsychiatric disorders, such as anxiety, epilepsy, pain, drug addiction, and Alzheimer'...

Full description

Saved in:
Bibliographic Details
Main Authors: Weijie Xie, Yuan Li, Xinyue Wang, Elena Blokhina, Evgeny Krupitsky, Marina Vetrova, Ji Hu, Ti‐Fei Yuan, Jue Chen, Hua Wang, Xiangfang Chen
Format: Article
Language:English
Published: Wiley 2025-05-01
Series:MedComm
Subjects:
Online Access:https://doi.org/10.1002/mco2.70163
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849736511567691776
author Weijie Xie
Yuan Li
Xinyue Wang
Elena Blokhina
Evgeny Krupitsky
Marina Vetrova
Ji Hu
Ti‐Fei Yuan
Jue Chen
Hua Wang
Xiangfang Chen
author_facet Weijie Xie
Yuan Li
Xinyue Wang
Elena Blokhina
Evgeny Krupitsky
Marina Vetrova
Ji Hu
Ti‐Fei Yuan
Jue Chen
Hua Wang
Xiangfang Chen
author_sort Weijie Xie
collection DOAJ
description ABSTRACT Gamma‐aminobutyric acid (GABA) B receptors (GABABRs) that acts slowly and maintains the inhibitory tone are versatile regulators in the complex nervous behaviors and their involvement in various neuropsychiatric disorders, such as anxiety, epilepsy, pain, drug addiction, and Alzheimer's disease. Additional study advances have implied the crucial roles of GABABRs in regulating feeding‐related behaviors, yet their therapeutic potential in addressing the neuropsychiatric disorders, binge eating, and feeding‐related disorders remains underutilized. This general review summarized the physiological structure and functions of GABABR, explored the regulation in various psychiatric disorders, feeding behaviors, binge eating, and metabolism disorders, and fully discussed the potential of targeting GABABRs and its regulator‐binding sites for the treatment of different psychiatric disorders, binge eating and even obesity. While agonists that directly bind to GABABR1 have some negative side effects, positive allosteric modulators (PAMs) that bind to GABABR2 demonstrate excellent therapeutic efficacy and tolerability and have better safety and therapeutic indexes. Moreover, phosphorylation sites of downstream GABABRs regulators may be novel therapeutic targets for psychiatric disorders, binge eating, and obesity. Further studies, clinical trials in particular, will be essential for confirming the therapeutic value of PAMs and other agents targeting the GABABR pathways in a clinical setting.
format Article
id doaj-art-09c32c46cf304663b16f8ac59c8c36a0
institution DOAJ
issn 2688-2663
language English
publishDate 2025-05-01
publisher Wiley
record_format Article
series MedComm
spelling doaj-art-09c32c46cf304663b16f8ac59c8c36a02025-08-20T03:07:16ZengWileyMedComm2688-26632025-05-0165n/an/a10.1002/mco2.70163GABAB Receptor: Structure, Biological Functions, and Therapy for DiseasesWeijie Xie0Yuan Li1Xinyue Wang2Elena Blokhina3Evgeny Krupitsky4Marina Vetrova5Ji Hu6Ti‐Fei Yuan7Jue Chen8Hua Wang9Xiangfang Chen10Clinical Research Center for Mental Disorders, Shanghai Pudong New Area Mental Health Center Tongji University School of Medicine Shanghai ChinaShanghai Key Laboratory of Psychotic Disorders, Brain Health Institute, National Center for Mental Disorders, Shanghai Mental Health Center Shanghai Jiaotong University School of Medicine Shanghai ChinaShanghai Key Laboratory of Psychotic Disorders, Brain Health Institute, National Center for Mental Disorders, Shanghai Mental Health Center Shanghai Jiaotong University School of Medicine Shanghai ChinaValdman Institute of Pharmacology Pavlov University St. Petersburg RussiaValdman Institute of Pharmacology Pavlov University St. Petersburg RussiaValdman Institute of Pharmacology Pavlov University St. Petersburg RussiaShanghaiTech University Shanghai ChinaShanghai Key Laboratory of Psychotic Disorders, Brain Health Institute, National Center for Mental Disorders, Shanghai Mental Health Center Shanghai Jiaotong University School of Medicine Shanghai ChinaShanghai Key Laboratory of Psychotic Disorders, Brain Health Institute, National Center for Mental Disorders, Shanghai Mental Health Center Shanghai Jiaotong University School of Medicine Shanghai ChinaDepartment of Oncology The First Affiliated Hospital of Anhui Medical University Hefei ChinaDepartment of Endocrinology Second Affiliated Hospital of Naval Medical University Shanghai ChinaABSTRACT Gamma‐aminobutyric acid (GABA) B receptors (GABABRs) that acts slowly and maintains the inhibitory tone are versatile regulators in the complex nervous behaviors and their involvement in various neuropsychiatric disorders, such as anxiety, epilepsy, pain, drug addiction, and Alzheimer's disease. Additional study advances have implied the crucial roles of GABABRs in regulating feeding‐related behaviors, yet their therapeutic potential in addressing the neuropsychiatric disorders, binge eating, and feeding‐related disorders remains underutilized. This general review summarized the physiological structure and functions of GABABR, explored the regulation in various psychiatric disorders, feeding behaviors, binge eating, and metabolism disorders, and fully discussed the potential of targeting GABABRs and its regulator‐binding sites for the treatment of different psychiatric disorders, binge eating and even obesity. While agonists that directly bind to GABABR1 have some negative side effects, positive allosteric modulators (PAMs) that bind to GABABR2 demonstrate excellent therapeutic efficacy and tolerability and have better safety and therapeutic indexes. Moreover, phosphorylation sites of downstream GABABRs regulators may be novel therapeutic targets for psychiatric disorders, binge eating, and obesity. Further studies, clinical trials in particular, will be essential for confirming the therapeutic value of PAMs and other agents targeting the GABABR pathways in a clinical setting.https://doi.org/10.1002/mco2.70163allosteric modulatorbinge eatingGABAB receptorsmetabolism disordersmolecular signalingpsychiatric disorders
spellingShingle Weijie Xie
Yuan Li
Xinyue Wang
Elena Blokhina
Evgeny Krupitsky
Marina Vetrova
Ji Hu
Ti‐Fei Yuan
Jue Chen
Hua Wang
Xiangfang Chen
GABAB Receptor: Structure, Biological Functions, and Therapy for Diseases
MedComm
allosteric modulator
binge eating
GABAB receptors
metabolism disorders
molecular signaling
psychiatric disorders
title GABAB Receptor: Structure, Biological Functions, and Therapy for Diseases
title_full GABAB Receptor: Structure, Biological Functions, and Therapy for Diseases
title_fullStr GABAB Receptor: Structure, Biological Functions, and Therapy for Diseases
title_full_unstemmed GABAB Receptor: Structure, Biological Functions, and Therapy for Diseases
title_short GABAB Receptor: Structure, Biological Functions, and Therapy for Diseases
title_sort gabab receptor structure biological functions and therapy for diseases
topic allosteric modulator
binge eating
GABAB receptors
metabolism disorders
molecular signaling
psychiatric disorders
url https://doi.org/10.1002/mco2.70163
work_keys_str_mv AT weijiexie gababreceptorstructurebiologicalfunctionsandtherapyfordiseases
AT yuanli gababreceptorstructurebiologicalfunctionsandtherapyfordiseases
AT xinyuewang gababreceptorstructurebiologicalfunctionsandtherapyfordiseases
AT elenablokhina gababreceptorstructurebiologicalfunctionsandtherapyfordiseases
AT evgenykrupitsky gababreceptorstructurebiologicalfunctionsandtherapyfordiseases
AT marinavetrova gababreceptorstructurebiologicalfunctionsandtherapyfordiseases
AT jihu gababreceptorstructurebiologicalfunctionsandtherapyfordiseases
AT tifeiyuan gababreceptorstructurebiologicalfunctionsandtherapyfordiseases
AT juechen gababreceptorstructurebiologicalfunctionsandtherapyfordiseases
AT huawang gababreceptorstructurebiologicalfunctionsandtherapyfordiseases
AT xiangfangchen gababreceptorstructurebiologicalfunctionsandtherapyfordiseases